13F Insight
DOSSIER · 13F Holders · Q2 2026
ADXN

ADDEX THERAPEUTICS LTD

3 institutions still hold ADDEX THERAPEUTICS LTD as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 00654J206·3 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$274
visible holders
Holders
3
filers reporting
Concentration
97.81%
UBS Group AG #1
top holder share
AI Holders Summary · Q2 2026

3 institutions reported ADXN in Q2 2026. UBS Group AG leads at 97.8% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
UBS Group AG
CIK 0001610520
$268470.00%Q2 202602
SBI Securities Co., Ltd.
CIK 0001851815
$610.00%Q2 202603
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
CIK 0000752798
$00—Q2 2025
Insiders at ADDEX THERAPEUTICS LTD
Teyssedou Lenaic Nathanael →Manke Isaac →Mills Roger →Nunn Jason Raleigh →